TruSpine Technologies Plc

Board/Management Information • Oct 12, 2022

National Storage Mechanism | Additional information

RNS Number : 6731C

TruSpine Technologies PLC

12 October 2022

TruSpine Technologies plc

("TruSpine" or the "Company")

Notice of Annual General Meeting

TruSpine Technologies plc (AQSE: TSP), the medical device company focused on the development of its pioneering "screwless", spinal (vertebral) stabilisation systems, announces that its Annual General Meeting ("AGM") for 2022 will be held at 9:00 am on Thursday 27 October 2022, at the Company's registered office, being Spectrum House, Af33, Beehive Ring Road, London Gatwick Airport, Gatwick, England, RH6 0LG.

The Notice of AGM is published and available on the "AGM" page on the Company's website (https://investors.truspine.org/investors/agm). A proxy form for the AGM is also available on the same web page.

Enquiries:

Truspine Technologies Plc		Tel: +44 (0)20 3638 5025
Ian Roberts, CEO
Cairn Financial Advisers LLP (AQSE Corporate Adviser)			Tel: +44 (0)20 7213 0880
Liam Murray / Ludovico Lazzaretti
Oberon Capital (Joint Broker)		Tel: +44 (0)20 3179 5300
Mike Seabrook / Chris Crawford
Peterhouse Capital Limited (Joint Broker & Financial Adviser) Lucy Williams / Duncan Vasey		Tel: +44 (0)20 7469 0930
Walbrook PR (Financial PR & IR)	Tel: +44 (0) 20 7933 7870 or +44 (0) 7876 741 001
Anna Dunphy		[email protected]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NEXFFLFFEEESESS